Special Commission on Xylazine -- 3-24-2026

Special Commission on Xylazine / Joint Committee on Mental Health, Substance Use and Recovery · March 24, 2026

0:00/1:10

1:10:19

0:00

20:00

40:00

1:00:00

1:10:00

Call to order and opening remarks

PresentationAnnouncement

1:07 → 3:33(2m 26s)

Chair Mindy Dahm (House Chair, Joint Committee on Mental Health, Substance Use and Recovery) opened the commission's final public meeting, thanked staff and commissioners, noted the meeting is recorded and archived, and announced the report submission deadline (March 30).

Keywords:

Speakers:

The Special Commission on Xylazine met to review and approve its final report, agree on editorial changes to appendices and language (including clarifications on drug-checking, emergency response and terminology), and vote to submit the report to the House and Senate clerks by March 30.

AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Transcript

Unlock the transcript with a paid subscription